MedChem Australia is delighted to announce our Round 2 Call for Project Applications is open. Researchers with innovative small molecule projects are invited to apply to access our expert medicinal chemistry and DMPK support.

Who Can Apply?

– Researchers from Australian universities

– Medical research institutes (MRIs)

– Small companies

Important Dates:

– Application Period: Now open

– Deadline: 5 pm on Monday, 24th February 2025

Prof. Brendon Monahan, MedChem Australia Director, said, “We look forward to our continued collaboration with the Australian biomedical research community to collectively develop much-needed safe and effective medicines.”

How to Apply: All the details regarding the application process and project requirements can be found on the “Working with us” section of our website. Discussions regarding potential applications are welcome at any time. You can schedule a call to discuss your project here.

MedChem Australia is a partnership between Monash University, WEHI and the University of Sydney, with funding from Therapeutic Innovation Australia and the Australian Government Medical Research Future Fund. MedChem Australia is dedicated to breaking down barriers in medicinal chemistry and DMPK capabilities, fostering partnerships that drive ground-breaking drug discovery. Through a collaborative cost-subsidised model, MedChem Australia provides resources and expertise to transform research into impactful medicines.